Robert J. Lechleider
Chief Medical OfficerDr. Robert J. Lechleider, also known as Bob, M.D., serves as Chief Medical Officer of at Immunome, Inc since October 2023. He served as Chief Medical Officer of OncoResponse, Inc. Dr. Lechleider joined OncoResponse from Seagen Inc. (formerly known as Seattle Genetics, Inc.). where he was Senior Vice President of Clinical Development since October 4, 2016 and was responsible for directing development of the early and late stage portfolios, including the successful initial licensing of Padcev for the treatment of previously treated metastatic urothelial cancer. Dr. Lechleider oversaw the development of ADCETRIS and more than 10 programs in growing oncology pipeline. He has wealth of clinical and biotechnology experience which helps Seattle Genetics continue to fulfill its mission of improving the health of people with cancer around the world. He served key roles at several biopharmaceutical companies, including MacroGenics and MedImmune and went on to positions of increasing responsibility at Human Genome Sciences and Macrogenics before heading development at Seagen. he was the Chief Development Sciences Officer at Molecular Templates, Inc. Before joining the biotechnology industry, he served as Assistant Professor of Pharmacology at Uniformed Services University of the Health Sciences and Associate Professor of Cell Biology at Georgetown University Medical School. He was also a Howard Hughes Medical Institute Scholar and a Damon Runyon-Walter Winchell postdoctoral fellow. Prior to joining Immunome, Dr. Tsai spent 21 years at Seagen and then Pfizer (following the acquisition of Seagen in December 2023) in positions of increasing responsibility. Dr. Lechleider received his A.B. cum laude from Princeton University and his M.D. from the University of Illinois College of Medicine at Chicago. He received clinical training in internal medicine at Beth Israel Hospital in Boston and in medical oncology at the National Cancer Institute in Bethesda.
Positions
- Company NameImmunome, Inc.Stock CodeIMNMPositionChief Medical OfficerColleagues
- CBClay B. SiegallChairman, President & CEO
- MRMax RosettChief Financial Officer
- PTPhilip TsaiChief Technical Officer
- JHJack HigginsChief Scientific Officer
- IBIsaac BarchasLead Independent Director
- JPJames Patrick BoylanIndependent Director
- CACarol A. SchaferIndependent Director
- PWPhilip WagenheimIndependent Director
